Fat and cholesterol diet induced lipid metabolic disorders and insulin resistance in rabbit

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 8, 2009, Pages 400-405

  Zheng, H ^a   Zhang, C ^a   Yang, W ^a   Wang, Y ^a   Lin, Y ^a   Yang, P ^a   Yu, Q ^a   Fan, J ^a,b   Liu, E ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Central obesity; Disorder; Hypertriglyceridemia; Insulin resistance; Rabbits

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; EXPERIMENTAL RABBIT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ANIMALS; AORTA; ATHEROSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; DIET, ATHEROGENIC; DIETARY FATS; FATTY LIVER; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID METABOLISM DISORDERS; MALE; RABBITS; RADIOIMMUNOASSAY; TIME FACTORS; TRIGLYCERIDES;

EID: 70350449644     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0028-1102918     Document Type: Article

References (34)

1. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985 6 45-86
2. Carroll JF, Dwyer TM, Grady AW, et al. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol 1996 271 373-378
3. Diniz YS, Faine LA, Galhardi CM, et al. Monosodium glutamate in standard and high-fiber diets: metabolicsyndrome and oxidative stress in rats. Nutrition 2005 21 749-755
4. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005 365 1415-1428
5. Fan J, Watanabe T. Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol Ther 2003 99 261-282
6. Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 1996 271 665-668
7. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993 259 87-91
8. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 683-689
9. Kagota S, Yamaguchi Y, Tanaka N, et al. Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 2006 78 1187-1196
10. Kawai T, Ito T, Ohwada K, et al. Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity: a novel model of metabolic syndrome. Arterioscler Thromb Vasc Biol 2006 26 2752-2757
11. Kearney MT, Duncan ER, Kahn M, et al. Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp Physiol 2008 93 158-163
12. Kitajima S, Morimoto M, Liu E, et al. Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits. Diabetologia 2004 47 1202-1209 (Pubitemid 39106830)
13. Koike T, Liang J, Wang X. Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J Biol Chem 2004 279 7521-7529
14. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 288 2709-2716
15. Lerman LO, Chade AR, Sica V, et al. Animal models of hypertension: an overview. J Lab Clin Med 2005 146 160-173
16. Liang J, Liu E, Yu Y, et al. Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation 2006 113 1993-2001
17. Liu E, Kitajima S, Higaki Y, et al. High lipoprotein lipase activity increases insulin sensitivity in transgenic rabbits. Metabolism 2005 54 132-138
18. Ma LJ, Mao SL, Taylor KL, et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 2004 53 336-346
19. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002 8 731-737
20. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 1999 107 450-455
21. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001 294 2166-2170
22. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999 892 146-154
23. Medina-Gomez G, Vidal-Puig A. Gateway to the metabolic syndrome. Nat Med 2005 11 602-603
24. Mondon CE, Dolkas CB, Oyama J. Enhanced skeletal muscle insulin sensitivity in year-old rats adapted to hypergravity. Am J Physiol 1981 240 482-488
25. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces athero-sclerosis in apolipoprotein E-deficient mice. Circulation 2002 106 2767-2770
26. Olefsky JM. The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest 1976 57 842-851
27. Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 2002 7 276-291
28. Randle PJ, Garland PB, Hales CN, et al. The glucose-fatty acid cycle: its role in insulin sensitivityand the metabolic disturbances of diabetes mellitus. Lancet 1963 13 785-789
29. Russell JC, Proctor SD. Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc Pathol 2006 15 318-330
30. Samuel VT, Liu ZX, Qu X, et al. Mechanism of hepatic insulin resist-ance in non-alcoholic fatty liver disease. J Biol Chem 2004 279 32345-32353
31. Shiomi M, Ito T, Yamada S, et al. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler Thromb Vasc Biol 2003 23 1239-1244
32. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 1980 36 261-268
33. Zhang B, Saku K, Hirata K, et al. Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril. Metabolism 1994 43 360-366
34. Zhao S, Chu Y, Zhang C, et al. Diet-induced central obesity and in-sulin resistance in rabbit. J Anim Physiol Anim Nutr (Berl) 2008 92 105-111